e-learning
resources
Vienna 2009
Monday, 14.09.2009
New insights in biology and treatment of pleural tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pleurodesis after intrapleural catheter insertion is an independent factor for overall survival in patients with malignant pleural effusions
C. A. Jimenez, B. Ozcakar, R. C. Morice, G. A. Eapen, R. F. Casal, H. T. Chiu, M. F. Munsell, C. L. Warneke, C. H. Martinez (Houston, Galveston, Dallas, United States Of America)
Source:
Annual Congress 2009 - New insights in biology and treatment of pleural tumours
Session:
New insights in biology and treatment of pleural tumours
Session type:
Oral Presentation
Number:
1799
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. A. Jimenez, B. Ozcakar, R. C. Morice, G. A. Eapen, R. F. Casal, H. T. Chiu, M. F. Munsell, C. L. Warneke, C. H. Martinez (Houston, Galveston, Dallas, United States Of America). Pleurodesis after intrapleural catheter insertion is an independent factor for overall survival in patients with malignant pleural effusions. Eur Respir J 2009; 34: Suppl. 53, 1799
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
LATE-BREAKING ABSTRACT: Spontaneous pleurodesis rates in chemotherapy and non-chemotherapy patients undergoing indwelling pleural catheter insertion for malignant pleural effusion
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016
Effectiveness and safety of tunneled pleural catheter placement in patients with malignant pleural effusions
Source: International Congress 2019 – Interventional pulmonology: current pleural practice
Year: 2019
Ultrasonographic predictors of spontaneous pleurodesis in malignant pleural effusion with pleural tunnelled catheters
Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside
Year: 2017
Predictors of successful pleurodesis for patients with malignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 493s
Year: 2004
The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 319s
Year: 2001
Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021
Malignant pleural disease in primary lung cancer
Source: Eur Respir Mon; 2009: 44: 318–335
Year: 2009
Talc pelurodesis vs tunneled pleural drainage in the malignant pleural effusion
Source: International Congress 2017 – Pleural interventions and transthoracic ultrasound (TUS)
Year: 2017
Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011
Indwelling pleural catheters vs. pleurodesis for malignant pleural effusions: a meta-analysis
Source: International Congress 2018 – Pleural interventions
Year: 2018
Impact of indwelling pleural catheter on quality of life in management of malignant pleural effusion in patients with advanced malignancies
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
An analysis of indwelling pleural catheter (IPC) insertions for malignant pleural effusions
Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases
Year: 2011
Efficacy of doxycycline with small-bore catheters in patients with malignant pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 772s
Year: 2006
Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy
Source: Annual Congress 2011 - From outside to inside: access to the pleura
Year: 2011
Pleurodesis in the treatment of malignant pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 628s
Year: 2004
Efficacy of talc pleurodesis in patients with malignant pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011
Talc pleurodesis in malignant pleural effusions: A 5-year experience
Source: Annual Congress 2012 - Medical access to the pleura
Year: 2012
Efficacy and safety of talc pleurodesis in patients with malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 754s
Year: 2006
Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 61s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept